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Abstract
Mitochondrial translational initiation factor 3 (IF3mt) is a 29 kDa protein that has N-and C-
terminal domains, homologous to prokaryotic IF3, connected by a linker region. The homology
domains are preceded and followed by short extensions. No information is currently available on
the specific residues in IF3mt important for its activity. Based on homology models of IF3mt,
mutations were designed in the N-terminal, C-terminal, and linker domains to identify the
functionally important regions. Mutation of residues 170–171, and 175 in the C-terminal domain
to alanine resulted in a nearly complete loss of activity in initiation complex formation and in the
dissociation of mitochondrial 55S ribosomes. However, these mutated proteins bind to the small
(28S) subunit of the mammalian mitochondrial ribosome with Kd values similar to the wild-type
factor. These mutations appear to lead to a factor defective in the ability to displace the large (39S)
subunit of the ribosome from the 55S monosomes in an active process. Other mutations in the N-
terminal domain, the linker region, and the C-terminal domain had little or no effect on the ability
of IF3mt to promote initiation complex formation on mitochondrial 55S ribosomes. Mutation of
residues 247–248 in the C-terminal extension abolished the ability of IF3mt to reduce the binding
of fMet-tRNA to the ribosome in the absence of mRNA. The results from this paper suggest that
IF3mt plays an active role in initiation of translation.
Over the past several years, understanding of mammalian mitochondria has become of
increasing interest as the involvement of these organelles in a variety of diseases has become
more apparent. In particular, dysfunctions in mitochondria and mutations in mitochondrial
DNA have been linked to genetic diseases, Alzheimers disease, Parkinsons disease, and
other age-related neurodegenerative diseases (1). Before the relationship between
mitochondria and disease states can be fully understood, a number of fundamental questions
about mitochondrial processes, including mitochondrial gene expression, must be answered.
Mammalian mitochondria contain about 16 kilobase pairs of DNA (2). This genetic
information encodes two ribosomal RNAs, 22 transfer RNAs, and 13 proteins. The DNA is
circular and continuous; it lacks significant non-coding regions. All of the proteins encoded
in this genome are hydrophobic membrane proteins that are subunits of either the oligomeric
electron transfer complexes or the ATP synthase required for the generation of energy by the
cell (2).
Translation of the mRNAs encoded by mitochondrial DNA requires the presence of a
protein biosynthetic system that is distinct from that of the cell cytoplasm. Mitochondrial
ribosomes are 55S particles that have about half the rRNA content and twice the protein
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content of bacterial ribosomes (3). Mitochondrial ribosomal subunits have sedimentation
coefficients of 28S and 39S, while bacterial ribosomal subunits have sedimentation
coefficients of 30S and 50S and form 70S monosomes.
Translation initiation factors have similarities in the bacterial and mitochondrial systems, but
several key differences are apparent. Three essential translation initiation factors have been
identified in Escherichia coli, while only two have been identified in the mitochondrial
system. In E. coli, IF2 promotes the binding of fMet-tRNA to the P-site of the 30S
ribosomal subunit and promotes the joining of the 30S and 50S ribosomal subunits (4).
Mitochondrial IF2 (IF2mt) appears to have the same fundamental activities found in its
bacterial counterpart. IF1 in E. coli is an essential 71 amino acid protein whose exact
function is unknown (5). No factor corresponding to IF1 has been identified in
mitochondria. However, IF2mt has a 37 amino acid insertion that is believed to function in
place of IF1 in translation (6).
In E. coli, IF3 is thought to have a number of roles. These include (1) dissociating of 70S
monosomes into subunits by the preferential binding of IF3 to the small ribosomal subunit,
(2) promoting the formation of initiation complexes, (3) proofreading initiation complexes
by dissociating those with non-canonical start codons, (4) promoting the shift of the mRNA
start codon into the P-site of the small subunit, and (5) mediating the codon/anticodon
interactions of the initiator tRNA (7–15). Like E. coli IF3, IF3mt stimulates initiation
complex formation in part by promoting the dissociation of 55S ribosomes, thereby
providing free small subunits for initiation complex formation. IF3mt has an additional role
not found in bacteria; it reduces the IF2mt-mediated binding of fMet-tRNA to 28S subunits
in the absence of mRNA (16). This observation suggests that mRNA binding normally
precedes fMet-tRNA binding in the mitochondrial system.
Following removal of the mitochondrial import signal, IF3mt is a 29 kDa protein composed
of three regions that have homology to the bacterial factor: the N-terminal domain, the
linker, and the C-terminal domain (Figure 1A). The N-terminal homology domain is
preceded by an extension of 31 amino acids, and the C-terminal domain is followed by an
extension of 33 amino acids. Most of the functions of E. coli IF3 and IF3mt tested in vitro
have been localized to the C-terminal domain. Full length IF3mt is thought to bind on the
interface side of the small subunit close to the platform with a Kd of 30 nM (17). The
isolated C-terminal domain of IF3mt also has a strong affinity for the 28S subunit and binds
with a Kd of 95 nM (17). The isolated N-terminal domain of E. coli IF3 has no detectable
binding to the 30S ribosomal subunit (12). This domain of IF3 is thought to increase the
affinity of the intact IF3 protein for the 30S subunit by two orders of magnitude. In contrast,
the isolated N-terminal domain of IF3mt binds to the 28S subunit with a Kd of 390 nM (17).
The N- and C-terminal extensions of IF3mt are not required for binding of the protein to the
small subunit, and removal of the extensions has almost no effect on the binding constant
(18). However, the C-terminal extension, along with the linker, plays a role in preventing
fMet-tRNA binding to the 28S subunit in the absence of mRNA (17).
MATERIALS AND METHODS
Materials
Laboratory supplies and chemicals were purchased from Sigma-Aldrich or Fisher Scientific.
A rabbit polyclonal primary antibody to the region of IF3mt homologous to the bacterial
factors was prepared as previously described (16). Bovine mitochondrial ribosomes (55S),
ribosomal subunits (28S and 39S), bovine IF2mt, and yeast [35S]fMet-tRNA were prepared
as described (19–21).
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Preparation of mutated derivatives of IF3mt
The sequence for IF3mt containing a 6× histidine tag was previously cloned into the pET21c
vector using NdeI and XhoI restriction sites (22). Twelve mutated derivatives, designated
IF3mt:1–12 (Table 1), were prepared by site-directed mutagenesis using the primers listed in
Table 2 and the QuikChange site-directed mutagenesis protocol (Stratagene). All mutations
were verified by DNA sequencing. The mutated plasmids were transformed into E. coli
BL21 RIL cells (Stratagene). Cells were grown to an A595 of 0.6 in LB media containing
ampicillin and chloramphenicol, at which time the expression of IF3mt was induced using 50
µM isopropyl β-D-1-thiogalactopyranoside. Cells were allowed to induce either overnight at
25 °C or for six h at 37 °C. After induction, cells were lysed and IF3mt was purified using
Ni-NTA resin followed by S-sepharose cation exchange chromatography or HPLC
purification using a TSKgel SP-5PW cation exchange column as described previously (19).
The IF3mt derivatives were tested for structural integrity by comparing the α-helical content
obtained using circular dichroism to that of wild-type IF3mt (IF3mt:WT). IF3mt:1 was
excluded from CD measurements due to the fact that it failed to separate from its truncated
19 kDa fragment during HPLC purification. All mutated proteins showed little or no change
in α-helical character as compared to the wild-type protein.
Preparation of polynucleotide phosphorylase
Initiation complex assays were carried out using poly(A,U,G) as the mRNA. Since this
polymer is no longer commercially available, it was prepared using polynucleotide
phosphorylase. The gene encoding E. coli polynucleotide phosphorylase was previously
cloned into the pET11a plasmid in BL21 (DE3) + pLysS cells and was a generous gift from
Dr. George H. Jones (Dept. of Biology, Emory University, Atlanta, GA) (23). The enzyme
was purified as described (23). To follow the enzyme during purification, activity assays
were carried out. Reaction mixtures (100 µL) contained 50 mM Tris-HCl, pH 8.0, 5 mM
MgCl2, 5 mM [3H]ADP (7 cpm/pmol), and 20 µL of appropriate fractions. The reactions
were incubated at 37 °C for 20 min, at which point 500 µg bovine serum albumin was added
and the reactions were precipitated with cold 5 % trichloroacetic acid (24). Following final
purification of the enzyme, fractions with ADP polymerization activity were pooled and
dialyzed against 50 % ammonium sulfate overnight without stirring at 4 °C.
Synthesis and purification of poly(A,U,G)
A 10 mL reaction containing 50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 5 mM ADP, pH 7.0,
5 mM UDP, pH 7.0, 5 mM GDP, pH 7.0, and 1 mg polynucleotide phosphorylase was
incubated at 37 °C overnight. Following synthesis, the reaction mixture was extracted using
phenol (pH 8.0)/chloroform, and the RNA was precipitated with ethanol overnight at −20
°C. RNA was collected by centrifugation at 15,000 rpm in the Sorvall SS-34 rotor for 30
min. The pellets were resuspended in 5 mL sterile H2O and applied to a Sephadex G-50
column (74 cm × 1.1 cm) equilibrated in 3 mM EDTA, pH 8.0, 25 mM Tris-HCl, pH 7.8.
The column was developed with 150 mL of the same buffer, and 1 mL fractions were
collected at a flow rate of 1 mL/min. UV absorbance was monitored at 260 nm. Fractions
containing poly(A,U,G) were pooled and precipitated using 2.5 volumes 100% ethanol
overnight at −20 °C. The poly(A,U,G) was collected by centrifugation at 15,000 rpm for 30
min in the SS-34 rotor and stored at −20 °C. Before use, the pellets were dissolved in sterile
H2O to a final concentration of 13 µg/µL.
Assay for initiation complex formation on E. coli or mitochondrial ribosomes
The effect of IF3mt and its mutated derivatives on the stimulation of [35S]fMet-tRNA
binding to either E. coli 70S or mitochondrial 55S ribosomes was measured using a filter
binding assay and scintillation counting as previously described (16,22). In the assay using
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E. coli ribosomes (100 µL), 2.5–10 pmol IF3mt (0.025–0.1 µM) was incubated with
saturating amounts of IF2mt (16 pmol, 0.16 µM), 70S ribosomes (68 µg, 0.3 µM),
poly(A,U,G) (5 µg, 0.05 µg/µL), and [35S]fMet-tRNA (6 pmol, 0.06 µM), under the ionic
conditions described previously (16). In the assay using mitochondrial 55S ribosomes, 1–4
pmol (0.01–0.04 µM) IF3mt was incubated with saturating amounts of IF2mt (16 pmol, 0.16
µM), 55S ribosomes (8 pmol, 0.08 µM), poly(A,U,G) (5 µg, 0.05 µg/µL), and [35S]fMet-
tRNA (6 pmol, 0.06 µM), under the assay conditions described previously (16).
Quantitation of the binding of IF3mt and its derivatives to mitochondrial 28S subunits
using Microcon centrifugation
Ribosome binding reactions were carried out as described (18). The indicated concentration
of IF3mt (0.15–1 pmol, 1.5–10 nM) was incubated with 28S subunits (5 pmol, 50 nM) for 20
min at 25 °C. IF3mt bound to 28S subunits was separated from free IF3mt using a Microcon
spin column (Millipore). IF3mt was then released from the ribosome by the addition of
EDTA to a final concentration of 20 mM. The amount of IF3mt bound to 28S subunits was
determined colorimetrically using a dot blot probed with antibodies against IF3mt as
described previously (18). A control curve for analysis of the dot blot was prepared by
spotting various concentrations of IF3mt (0.5–1.2 pmol, 5–12 nM), 28S (5 pmol, 50 nM),
and EDTA (20 mM) directly onto the dot blot nitrocellulose membrane to quantify the
change in color versus the amount of protein.
Dissociation of mitochondrial 55S ribosomes by IF3mt and its mutated derivatives
Mitochondrial 55S ribosomes (8 pmol, 0.08 µM) were incubated in a buffer containing 50
mM Tris-HCl, pH 7.6, 5 mM MgCl2, 40 mM KCl, and 1 mM dithiothreitol in the absence or
presence of 80 pmol (0.8 µM) IF3mt or its mutated derivatives in 100 µL at 37 °C for 15
min. The samples were placed on ice for 10 min and then loaded onto a 10–30 % sucrose
gradient and analyzed as previously described by monitoring the A254 during fractionation
of the gradient (18). Each 55S ribosome sample contained some free 39S subunits.
Therefore, the percentage of 55S particles was determined by comparing the area of the 55S
peak on the absorbance profile to the total area of the 28S, 39S, and 55S peaks combined to
account for this contamination. Areas under the peaks were determined using the width of
the peak at ½ the maximal height multiplied by the height. To determine the percentage
dissociation, the amount of 55S particles in the absence of IF3mt was set to 100% and
compared to the amount of 55S particles observed in the presence of IF3mt.
Inhibition of fMet-tRNA binding to 28S subunits by IF3mt in the absence of mRNA
The inhibition of [35S]fMet-tRNA binding to 28S subunits in the absence of mRNA was
tested as described (16). Small subunits (6.2 pmol, 0.062 µM) were incubated with
saturating amounts of IF2mt (25 pmol, 0.25 µM) and [35S]fMet-tRNA (5 pmol, 0.05 µM) in
the presence or absence of IF3mt (0–12 pmol, 0–0.12 µM) or its C-terminal extension
mutated derivatives for 15 min at 25 °C in 100 µL reaction mixtures. The amount of
[35S]fMet-tRNA remaining bound to the subunits was determined using a nitrocellulose
filter binding assay (25).
RESULTS
Design of IF3 mutations
A model of IF3mt was developed using the modeling program Insight II (Figure 1B). The N-
terminal domain was modeled after the crystal structure of the Bacillus stearothermophilus
IF3 (PDB coordinates 1TIF (26)). This region of IF3 folds into a mixed 4-stranded β-sheet
packed against a single helical unit (Helix 1) lying across the sheet and a second α-helix
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(Helix 2) extending into the linker region. The model of the N-terminus of IF3mt is quite
similar to that of the crystal structure of the B. stearothermophilus factor despite the low
percent identity (<23 %) between the N-terminal domains. The C-terminal domain was
modeled after the NMR structure of the mouse IF3mt (PDB coordinates 2CRQ, to be
published) which has been shown to consist of two α-helices (H3 and H4) lying on top of a
4-stranded β-sheet. The sequence of the C-terminal domain of the human factor is 72 %
identical to that of mouse IF3mt. The predicted structure of this domain of human IF3mt is
quite similar to that of the mouse factor except that one of the β-strands is modeled in two
sections due to the presence of an internal proline residue. In the model, the linker region is
depicted as being partially α-helical. However, biochemical studies of the linker regions of
IF3 from several sources suggest that this region has considerable flexibility 17,27–29). The
model does not include the N- and C-terminal extensions, which were predicted to be
disordered. In the current work, a number of residues in IF3mt, predicted to lie on the surface
of the protein, were mutated, and the effects of these mutations on the ability of IF3mt to
promote initiation complex formation and to bind to 28S subunits were examined.
Mitochondrial 55S ribosomes are composed of approximately 2/3 protein and 1/3 RNA. The
interface between the 28S and 39S subunits is rich in RNA (3). Significant electrostatic
interactions between IF3mt (pI ~10) and the 12S small subunit rRNA are expected to play an
important role in the function of this factor. To identify residues in IF3mt potentially
involved in binding to the small subunit or in other functions of this factor, clusters of
charged amino acids predicted to be exposed on the surface in the model of IF3mt (Figure
1B) were changed to alanine (Figure 2). Twelve different mutated derivatives (IF3mt:1–12)
were made in the N- and C-terminal domains, the linker, and the C-terminal extension. The
charges of these residues are generally conserved among vertebrate IF3mt, and partially
conserved with the mosquito, fruit fly, and bacterial factors (Figure 2A). No mutations were
made in the N-terminal extension, because this region is poorly conserved and no known
function has been attributed to the N-terminal extension alone.
The N-terminal domain of E. coli IF3 does not bind independently to 30S subunits (12). In
contrast, the N-terminal domain of IF3mt binds 28S subunits with a Kd of 390 ± 60 nM (17).
Two clusters of residues in the N-terminal domain were mutated (Figure 2). The selected
residues were fairly well conserved among the mammalian factors (Figure 2A) but less
conserved with the IF3mt of other organisms. IF3mt:1 is located five residues into the N-
terminal domain of IF3mt in a region where no structural information is available. Its
predicted location is shown in the model (Figure 2C). This region was selected for
mutagenesis since the first six residues of E. coli IF3 are important for the function of this
factor (30). IF3mt:2 is also located in the N-terminal domain in a loop between two β-strands
facing away from the linker region. IF3mt:3 is located in a predicted α-helical region in the
IF3mt linker. IF3mt:4–6 are located in the C-terminal domain of IF3mt in an α-helix (Helix 3)
predicted previously to be essential for the function of the E. coli protein (31). IF3mt:7 is
also in the C-terminal domain at the tip of a β- strand (corresponding to β-strand 7 in the
prokaryotic factors) in the center of the domain. IF3mt:8 is located behind IF3mt:7 on the
opposite face of the C-terminal domain (Figure 2C). IF3mt:9–12 are located in the C-
terminal extension of IF3mt, where no structural data is currently available. A summary of
the IF3mt mutations is shown in Table 1.
The mutated proteins were purified and tested for structural integrity by measuring the α-
helical content using circular dichroism. The activities of the derivatives in promoting fMet-
tRNA binding to E. coli and mitochondrial ribosomes were tested. Proteins that showed
reduced activity in promoting initiation complex formation were further tested for their
abilities to dissociate mitochondrial 55S ribosomes. Those unable to dissociate 55S
ribosomes were tested for their abilities to bind to mitochondrial 28S small subunits.
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Mutations in the N-terminal domain and linker
IF3mt derivatives with mutations in the N-terminal domain and linker were tested for their
abilities to promote fMet-tRNA binding to both E. coli and mitochondrial ribosomes in the
presence of IF2mt. This assay primarily measures the ribosomal subunit dissociation activity
of this factor (22). A representative graph showing initiation complex formation as a
function of increasing amounts IF3mt is shown in Figure 3A. IF3mt:1 and IF3mt:2 showed
activity similar to the unmutated factor (IF3mt:WT) on both E. coli and mitochondrial
ribosomes (Figure 3B), indicating that these residues are not important for the activity of this
protein. IF3mt:3, located in the linker region of the protein, showed a slight reduction in
activity in initiation complex formation on both E. coli and mitochondrial ribosomes (Figure
3B). The slight loss of activity for IF3mt:3 was further explored in an assay that measures
the ability of the protein to dissociate mitochondrial 55S ribosomes as described below.
IF3mt:3 showed the same subunit dissociation pattern as the wild-type protein in this assay,
which indicates that it did not have any significant defect in this function (Figure 4D).
Mutations in the C-terminal domain
The C-terminal domain of IF3mt with the linker binds to the small ribosomal subunit with
nearly the same affinity as the full-length protein and shows the same activity as the full
length protein in stimulating fMet-tRNA binding to mitochondrial ribosomes (17). IF3mt
derivatives with mutations in the C-terminal domain were tested for activity in initiation
complex formation on E. coli and mitochondrial ribosomes. IF3mt:7 and IF3mt:8 had the
same activity as the wild-type protein (Figure 3). IF3mt:4 showed slightly reduced activity,
but still maintained its ability to dissociate 55S ribosomes as well as the wild-type protein
(Figure 4). However, IF3mt:5 and IF3mt:6 had almost no activity in promoting initiation
complex formation on E. coli ribosomes, and had significantly reduced activity on
mitochondrial ribosomes (Figure 3).
Since neither IF3mt:5 nor IF3mt:6 were active in stimulating initiation complex formation, an
assay that basically measures ribosome dissociation, their abilities to promote the
dissociation of 55S ribosomes was examined directly by sucrose density centrifugation.
Both proteins were deficient in dissociation activity (Figure 4). IF3mt:5 dissociated 55S
ribosomes by only ~15 %, compared to just over 50 % dissociation with the same level of
IF3mt:WT. IF3mt:6 had essentially no activity in the ribosome dissociation assay.
One possible explanation for the lack of activity observed with IF3mt:5 and IF3mt:6 is that
these mutated proteins are unable to bind 28S subunits, and, therefore, are unable to
effectively prevent the interaction of the 28S and 39S ribosomal subunits. To test this
possible explanation directly, the binding of IF3mt and its mutated derivatives to 28S
subunits was measured using Microcon-100 centrifugation followed by immunological
detection of IF3mt on a dot blot apparatus (18). This method takes advantage of the
observation that, in the absence of 28S subunits, IF3mt passes through the membrane while
IF3mt bound to 28S subunits does not. IF3mt:WT binds to 28S subunits with a Kd of 35 ± 13
nM (Table 2). As indicated in Figure 5, IF3mt:6 binds 28S subunits with a Kd of 45 ± 17 nM
and IF3mt:5 binds to 28S subunits with a Kd of 19 ± 11 nM. Since both mutated proteins
show the same binding to 28S subunits as IF3mt:WT, the lack of activity of the mutated
proteins in initiation complex formation and in the dissociation of 55S ribosomes into the
28S and 39S subunits cannot be attributed to a defect in their abilities to bind the small
ribosomal subunit.
Mutations in the C-terminal extension
One unusual property of IF3mt is that its C-terminal extension is thought to play an
important role in decreasing the amount of fMet-tRNA bound to mitochondrial 28S subunits
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in the absence of mRNA. This observation suggests that mRNA binding should precede
fMet-tRNA binding in the mitochondrial system (16). No structural data is currently
available for the C-terminal extension of IF3mt. Modeling of this region indicated that it is
probably disordered in solution. Regions of highly charged amino acids (acidic and basic)
conserved in vertebrate IF3mt lineages were selected for mutation to alanine residues (Figure
2). All of these derivatives were as active as IF3mt:WT in promoting initiation complex
formation on both E. coli and mitochondrial ribosomes (Figure 3). As indicated in Figure 6,
IF3mt:WT inhibits the binding of fMet-tRNA to 28S subunits in the absence of mRNA.
IF3mt:5 and IF3mt:6 in the C-terminal domain, along with IF3mt:10, IF3mt:11, and IF3mt:12
in the C-terminal extension showed normal activity in this assay (data not shown). However,
IF3mt:9, also in the C-terminal extension, was unable to reduce the amount of fMet-tRNA
bound to ribosomes in the absence of mRNA (Figure 6). This observation pinpoints a region
of the C-terminal extension that is critical for inhibiting initiation complex formation before
the mRNA is bound. Interestingly, the linker region of IF3mt also appears to have a role in
preventing fMet-tRNA binding in the absence of mRNA (17).
The C-terminal extension is predicted to emerge from the C-terminal domain near the linker
region according to the model (Figure 1B). The linker, and, thus, the C-terminal extension,
may span the region between the platform, where the C-terminal domain is thought to bind,
and the head of the small subunit. The linker may be positioned toward the mRNA binding
channel as predicted in the model of McCutcheon et al. (13). A transient association
between of these regions of IF3mt with the mRNA channel near the P-site may permit this
factor to distinguish prematurely formed initiation complexes.
DISCUSSION
Comparison of mutational effects in IF3mt and E. coli IF3
Both NMR (32) and mutational analysis (31,33) indicate that there are a number of contacts
between E. coli IF3 and the small subunit in the C-terminal domain. These interactions
appear to span much of Helix 3, the loop regions, and portions of Helix 4. Key differences
between IF3mt and the E. coli factor become apparent when the extensive battery of
mutations made in made in Arg residues in E. coli IF3 are compared to those presented here
in the mitochondrial factor (Figure 7). In E. coli IF3, the most drastic effects on the activity
of the factor in initiation complex formation measured by ribosomal subunit dissociation
were caused by a mutation in the center of Helix 4 in the C-terminal domain (31). This
mutation also caused significant reductions in binding of the mutated protein to E. coli 30S
ribosomal subunits, suggesting that the defect in initiation arises from a weaker interaction
with the small subunit. However, IF3mt:8, located in Helix 4 in the C-terminal domain of
IF3mt, was able to stimulate initiation complex formation as well as the wild-type factor.
This observation suggests that residues in Helix 4 may play a less important role in IF3mt
than in E. coli IF3.
In the mitochondrial factor, the most drastic effects were seen with two mutations in Helix 3
(IF3mt:5 and IF3mt:6, Figure 7). A mutation made in the center of this helix in E. coli IF3
(R112S) had only a modest effect on initiation complex formation (31), and the mutated
derivative still retained >60 % of the activity observed with the wild-type factor. In the
mitochondrial factor, the mutations in Helix 3 are located closer to the base of the helix
rather than in the center. The side chains of these residues are predicted to be shifted
approximately 90 degrees towards the front of the protein when compared to the side chain
of the mutated residues in E. coli IF3. IF3mt derivatives containing these mutations do not
promote initiation complex formation, but are still able to bind to mitochondrial 28S
subunits. Thus, residues near to the bottom of Helix 3 are not predicted to be in direct
Christian and Spremulli Page 7













contact with the 28S subunits. Rather, they may define a surface of IF3mt that contacts the
39S subunit during the dissociation of the 55S ribosomes into subunits.
Model for IF3mt-mediated dissociation of 55S ribosomes
Mutation of residues 170–171 and residue 175 in Helix 3 of the C-terminal domain of IF3mt
drastically reduced the activity of IF3mt in promoting initiation complex formation. This
assay basically measures the ability of IF3mt to dissociate 55S ribosomes. Sucrose density
gradient centrifugation confirmed the idea that these mutations inactivate IF3mt in ribosomal
subunit dissociation. The most logical explanation for these results is that the mutated
proteins fail to bind mitochondrial 28S subunits and, therefore, cannot prevent 39S joining.
However, both of these mutated derivatives of IF3mt bind to 28S subunits as well as the
wild-type factor (Table 3). This observation indicates that an alternative problem must
underlie the loss of activity in these mutated IF3mt derivatives. One possible explanation is
that there are two distinct functionally important surfaces of IF3mt. The first surface would
function as a dissociation interface and may interact with one or both of the ribosomal
subunits. The second surface would function as a binding interface between the factor and
the 28S subunit.
Recent work has indicated that the position of the C-terminal domain of E. coli IF3 blocks
bridge B2b of the 70S ribosome, preventing the association of the large and small subunits
when IF3 is present (14). Bridge B2b involves 16S rRNA nucleotide 794 (34), which is in
proximity to the proposed IF3 binding site on the 30S subunit (8,35). Cryo-electron
microscopy studies of mammalian mitochondrial ribosomes (3) indicates that this
intersubunit bridge is one of several conserved contacts between the two subunits. IF3mt is
expected to bind to 28S subunits in a manner similar to the binding of E. coli IF3 to 30S
subunits. It is likely that residues 170–171 and 175 play an essential role in allowing IF3mt
to block the formation of bridge B2b. Mutation of these residues could impede the blocking
this intersubunit bridge by IF3mt, preventing these mutated forms of IF3mt from effectively
competing with the 39S subunit for binding to the 28S subunit.
There are two current models to explain the action of IF3mt in ribosomal subunit
dissociation (Figure 8). In the passive model, IF3mt binds to 28S subunits after the subunits
dissociate transiently (Figure 8A, passive model). In this model, IF3mt acts more as an anti-
association factor than a dissociation factor (36). In the active model, an equilibrium exists
between 55S ribosomes and a transient 28S:IF3:39S complex (Figure 8B, active step 1).
This transient complex is in equilibrium with free 39S subunits and 28S subunits bound to
IF3mt (active step 2). The active model suggests that IF3mt plays a more direct role in
dissociating 55S ribosomes than simply binding to 28S subunits that are present at
equilibrium. IF3mt: 5 and IF3mt:6, though they bind well to 28S subunits (active step 1), are
deficient in dissociating 55S ribosomes (active step 2). This observation suggests that a
transient 28S:IF3:39S complex formed by these mutated derivatives fails to dissociate into
its component subunits. This idea is supposed by recent kinetic data, which suggest that in
E. coli, IF3 may remain associated with the 30S subunit that is partially bound to the 50S
(14), and by recent cryo-electron microscopy data, which tentatively suggests that IF3 may
not be released from 70S particles until the hydrolysis of GTP by IF2 has occurred (37). The
present results suggest that IF3mt plays an active role rather than a passive role in ribosomal
subunit dissociation in the mitochondrial translational system.
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REFERENCES
1. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
Nature. 2006; 443:787–795. [PubMed: 17051205]
2. Scheffler, I. Mitochondria. New York: Wiley-Liss, Inc; 1999.
3. Sharma MR, Koc EC, Datta PP, Booth TM, Spremulli LL, Agrawal RK. Structure of the
mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins.
Cell. 2003; 115:97–108. [PubMed: 14532006]
4. Gualerzi C, Pon C. Initiation of mRNA translation in prokaryotes. Biochemistry. 1990; 29:5881–
5889. [PubMed: 2200518]
5. Cummings H, Hershey J. Translation initiation factor IF-1 is essential for cell viability in
Escherichia coli . J. Bacteriol. 1994; 176:198–205. [PubMed: 8282696]
6. Gaur R, Grasso D, Datta PP, Krishna PDV, Das G, Spencer A, Agrawal RK, Spremulli L, Varshney
U. A single mammalian mitochondrial translation initiation factor functionally replaces two
bacterial factors. Mol. Cell. 2008; 29:180–190. [PubMed: 18243113]
7. Dottavio-Martin D, Suttle DP, Ravel JM. The effects of initiation factors IF-1 and IF-3 on the
dissociation of Escherichia coli 70 S ribosomes. FEBS Lett. 1979; 97:105–110. [PubMed: 367813]
8. Dallas A, Noller HF. Interaction of translation initiation factor 3 with the 30S ribosomal subunit.
Mol. Cell. 2001; 8:855–864. [PubMed: 11684020]
9. Paci M, Pon C, Lammi M, Gualerzi C. Structure-function relationship in Escherichia coli
translational initiation factors. Characterization of IF-3 by high resolution 1H NMR spectroscopy. J.
Biol. Chem. 1984; 259:9628–9634. [PubMed: 6378910]
10. La Teana A, Gualerzi C, Brimacombe R. From stand-by to decoding site. Adjustment of the
mRNA on the 30 S subunit under the influence of the initiation factors. RNA. 1995; 1:772–782.
[PubMed: 7493323]
11. Antoun A, Pavlov MY, Lovmar M, Ehrenberg M. How initiation factors tune the rate of initiation
of protein synthesis in bacteria. EMBO J. 2006; 25:2539–2550. [PubMed: 16724118]
12. Petrelli D, LaTeana A, Garofalo C, Spurio R, Pon CL, Gualerzi CO. Translation initiation factor
IF3: two domains, five functions, one mechanism? EMBO J. 2001; 20:4560–4569. [PubMed:
11500382]
13. McCutcheon J, Agrawal R, Philips SM, Grassucci R, Gerchman S, Clemons WM, Ramakrishnan
V, Frank J. Location of translational initiation factor IF3 on the small ribosomal subunit. Proc.
Natl. Acad. Sci. U.S.A. 1999; 96:4301–4306. [PubMed: 10200257]
14. Fabbretti A, Pon CL, Hennelly SP, Hill W, Lodmell J, Gualerzi CO. The real-time path of
translation factor IF3 onto and off the ribosome. Mol. Cell. 2007; 25:285–296. [PubMed:
17244535]
15. Laursen BS, Sorensen HP, Mortensen KK, Sperling-Petersen HU. Initiation of protein synthesis in
bacteria. Microbiol. Mol. Biol. Rev. 2005; 69:101–123. [PubMed: 15755955]
16. Bhargava K, Spremulli LL. Role of the N- and C-terminal extensions on the activity of mammalian
mitochondrial translational initiation factor 3. Nucleic Acids Res. 2005; 33:7011–7018. [PubMed:
16340009]
17. Haque M, Spremulli LL. Roles of the N- and C-terminal domains of mammalian mitochondrial
initiation factor 3 in protein biosynthesis. J. Mol. Biol. 2008; 384:929–940. [PubMed: 18930736]
Christian and Spremulli Page 9













18. Haque ME, Grasso D, Spremulli LL. The interaction of mammalian mitochondrial translational
initiation factor 3 with ribosomes: Evolution of terminal extensions in IF3mt . Nucleic Acids Res.
2008; 36:589–597. [PubMed: 18056078]
19. Grasso DG, Christian BE, Spencer AC, Spremulli LL. Over-expression and purification of
mitochondrial translational initiation factor 2 and initiation factor 3. Meth. Enzymol. Translation
Initiation: Reconstituted Systems and Biophysical Methods. 2007:59–78.
20. Spremulli, LL. Methods Mol. Biol. Mitochondria, Practical Protocols. Leister, D.; Herrmann, J.,
editors. Totowa, NJ: Humana Press; 2007. p. 265-275.
21. Graves M, Spremulli LL. Activity of Euglena gracilis chloroplast ribosomes with prokaryotic and
eukaryotic initiation factors. Arch. Biochem. Biophys. 1983; 222:192–199. [PubMed: 6404223]
22. Koc EC, Spremulli LL. Identification of mammalian mitochondrial translational initiation factor 3
and examination of its role in initiation complex formation with natural mRNAs. J. Biol. Chem.
2002; 277:35541–35549. [PubMed: 12095986]
23. Jones GH, Symmons MF, Hankins JS, Mackie GA. Overexpression and purification of untagged
polynucleotide phosphorylases. Protein Expression Purif. 2003; 32:202–209.
24. Spencer AC, Heck AH, Takeuchi N, Watanabe K, Spremulli LL. Characterization of the human
mitochondrial methionyl-tRNA synthetase. Biochemistry. 2004; 43:9743–9754. [PubMed:
15274629]
25. Liao H-X, Spremulli LL. Initiation of protein synthesis in animal mitochondria: Purification and
characterization of translational initiation factor 2. J. Biol. Chem. 1991; 266:20714–20719.
[PubMed: 1939122]
26. Biou V, Shu F, Ramakrishnan V. X-ray crystallography shows that translational initiation factor
IF3 consists of two compact α/β domains linked by an α-helix. EMBO J. 1995; 14:4056–4064.
[PubMed: 7664745]
27. Moreau M, de Cock E, Fortier P-L, Garcia C, Albaret C, Blanquet S, Lallemand J-Y, Dardel F.
Heteronuclear NMR studies of E. coli translation initiation factor IF3. Evidence that the inter-
domain region is disordered in solution. J. Mol. Biol. 1997; 266:15–22. [PubMed: 9054966]
28. Hua Y, Raleigh D. On the global architecture of initiation factor IF3: a comparative study of the
linker regions from the Escherichia coli protein and the Bacillus stearothermophilus protein. J.
Mol. Biol. 1998; 278:871–878. [PubMed: 9614948]
29. de Cock E, Springer M, Dardel F. The interdomain linker of Escherichia coli initiation factor IF3: a
possible trigger of translation initiation specificity. Mol. Microbiol. 1999; 32:193–202. [PubMed:
10216872]
30. Lammi M, Pon C, Gualerzi C. The NH2-terminal cleavage of Escherichia coli translational
initiation factor 3: A mechanism to control the intracellular level of the factor. FEBS Lett. 1987;
215:115–121. [PubMed: 3552730]
31. Petrelli D, Garofalo C, Lammi M, Spurio R, Pon CL, Gualerzi CO, Teana AL. Mapping the active
sites of bacterial translation initiation factor IF3. J. Mol. Biol. 2003; 331:541–556. [PubMed:
12899827]
32. Sette M, Spurio R, VanTilborg P, Gualerzi C, Boelens R. Identification of the ribosome binding
sites of translation initiation factor IF3 by multidimensional heteronuclear NMR spectroscopy.
RNA. 1999; 5:82–92. [PubMed: 9917068]
33. Bellis D, Liveris D, Goss D, Ringquist S, Schwartz I. Structure-function analysis of Escherichia
coli translation initiation factor 3: Tyrosine 107 and lysine 110 are required for ribosome binding.
Biochemistry. 1992; 31:11984–11990. [PubMed: 1457399]
34. Liiv A, O'Connor M. Mutations in the intersubunit bridge regions of 23S rRNA. J. Biol. Chem.
2006; 281:29850–29862. [PubMed: 16891309]
35. Tapprich W, Goss D, Dahlberg A. Mutation at position 791 in Escherichia coli 16 S ribosomal
RNA affects processes involved in the initiation of protein synthesis. Proc. Natl. Acad. Sci. U.S.A.
1989; 86:4927–4931. [PubMed: 2662189]
36. Naaktgeboren N, Roobol K, Voorma HO. The effect of initiation factor IF-1 on the dissociation of
70S ribosomes of Escherichia coli . Eur. J. Biochem. 1977; 72:49–56. [PubMed: 319002]
37. Allen GS, Zavialov A, Gursky R, Ehrenberg M, Frank J. The cryo-EM structure of a translation
initiation complex from Escherichia coli . Cell. 2005; 121:703–712. [PubMed: 15935757]
Christian and Spremulli Page 10













38. Garcia C, Fortier P-L, Blanquet S, Lallemand J-Y, Dardel F. 1H and 15N resonance assignments
and structure of the N-terminal domain of Escherichia coli initiation factor 3. Eur. J. Biochem.
1995; 228:395–402. [PubMed: 7705354]
Christian and Spremulli Page 11














Domain organization and model of IF3mt. A. Schematic representation of E. coli IF3 and
IF3mt showing the N- and C-terminal homology domains and the linker regions. IF3mt has
additional N- and C-terminal extensions not present in the E. coli factor. The leader specifies
mitochondrial import and is not present in the constructs used here. B. The 3-D model of
IF3mt prepared using Insight II. The N-terminal domain was modeled after the crystal
structure of the N-terminal domain of B. stearothermophilus IF3 (PDB coordinates 1TIF
(26)), and the C-domain was modeled after the NMR structure of the mouse IF3mt (PDB
coordinates 2CRQ, unpublished). The N- and C-terminal extensions are not shown and are
predicted to be disordered.
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Mutations in IF3mt. A. Conservation of the charged residues mutated in IF3mt:1–8.
Positively charged residues are shown in dark gray and negatively charged residues are
shown in light gray. The numbers above each cluster of residues indicates the IF3mt
derivative containing mutations of those residues. B. stearothermophilus IF3 does not have
residues corresponding to IF3mt:1. These residues are present in E. coli IF3 as KRVQT. B.
Sequence conservation of IF3mt:9–12 among the vertebrate lineage. Positively charged
residues are shown in dark gray and negatively charged residues are shown in light gray. C.
Model of IF3mt showing IF3mt:1–8. The N-terminal domain is shown in red, the linker is in
green, and the mutated residues are in blue. IF3mt:1 could not be modeled based on the
crystal structure of B. stearothermophilus because these residues are not present in this IF3
nor are they present in the NMR structure of the N-domain of E. coli IF3 (38). IF3mt:1 has
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been placed in the model at the N-terminus of the protein for illustrative purposes. The C-
terminal homology domain is shown in blue and the mutated residues are shown in orange.
Part of the C-terminal extension is shown in yellow.
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Effect of mutated derivatives of IF3mt on initiation complex formation. A. Effect of
IF3mt:WT, IF3mt:7, and IF3mt:5 on initiation complex formation on mitochondrial 55S
ribosomes. [35S]fMet-tRNA binding to mitochondrial 55S particles was tested in the
presence of saturating amounts of IF2mt using IF3mt:WT (●), IF3mt:7 (■), or IF3mt:5 (◆).
A blank representing the amount of [35S]fMet-tRNA bound to ribosomes in the absence of
IF3mt (~0.1 pmol) was subtracted from each value. B. Summary of the activities of IF3mt:1–
12 in initiation complex formation. This assay primarily measures ribosome dissociation.
The activity of IF3mt:WT was set to 100 % and the mutated derivatives were compared to
that value using the linear regions of the dose response curves. The activity on 70S
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ribosomes is shown in gray while activity on mitochondrial ribosomes is in striped gray.
Derivatives identical to wild-type within error are shown as 100 %.
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Effect of IF3mt and its mutated derivates on the dissociation of mitochondrial 55S
ribosomes. Fractionation profiles of mitochondrial 55S ribosomes after centrifugation on a
10– 30 % sucrose gradient. Mitochondrial 55S ribosomes (8 pmol) were incubated as
described in Materials and Methods in the absence (A) or presence of 80 pmol IF3mt (B) or
its mutated derivative IF3mt:6 (C) and subsequently subjected to centrifugation on a 10–30
% sucrose density gradient. Gradients were fractionated while monitoring the A254. D.
Percentage of mitochondrial 55S ribosomes remaining after the addition of IF3mt:WT or its
mutated derivatives as measured by sucrose density gradient centrifugation.
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Binding of IF3mt:6 to 28S subunits. Binding assays were performed using a Microcon spin
column as described (18). Inset: Calibration curve of IF3mt: WT using a colorimetric assay
and a dot blot apparatus. This curve was used to determine the amount of IF3mt bound to
mitochondrial 28S ribosomes in the Microcon centrifugation assay as described in Materials
and Methods.
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IF3mt-mediated inhibition of fMet-tRNA binding to mitochondrial 28S subunits in the
absence of mRNA. Mitochondrial 28S subunits were incubated with saturating amounts of
IF2mt and [35S]fMet-tRNA in the presence or absence of IF3mt:WT or its C-terminal
extension mutated derivative IF3mt:9 as described (16). The amount of [35S]fMet-tRNA
remaining bound to the filter in the presence of IF3mt:WT (■) or IF3mt:9 (●) was
determined using a nitrocellulose filter binding assay.
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Effects of mutations in the C-terminal domain of E. coli IF3 and IF3mt. A. Mutated residues
in the C-terminal domain of E. coli IF3 and their effects on activity in initiation complex
formation on E. coli ribosomes. The activity remaining was based on 70S dissociation, one
of several assays carried out with these mutated derivatives of E. coli IF3. The most drastic
effects on activity are seen with the mutation in the center of the α-helix (Helix 4) on the
back of the protein. B. Mutated residues in the C-terminal domain of IF3mt and the effects of
these mutations on activity in initiation complex formation on mitochondrial ribosomes. The
most drastic effects are seen with the two mutations located at the base of Helix 3.
Christian and Spremulli Page 20














Models for the mechanism of IF3mt in the dissociation of mitochondrial ribosomes. A. In the
passive model, the subunits are in equilibrium with the 55S monosome (passive step 1).
IF3mt binds to free 28S subunits, preventing reassociation with the 39S subunit (passive step
2). B. In the active model, IF3mt interacts with the 55S particle, forming a transient
28S:IF3mt:39S complex (active step 1), which then dissociates into a 28S:IF3mt complex
and free 39S subunits (active step 2).
Christian and Spremulli Page 21

























Christian and Spremulli Page 22
Table 1




IF3mt:1 N-domain KKTKK (66–70) AATAA
IF3mt:2 N-domain TSTE (121–124) AAAA
IF3mt:3 Linker REMEK (143–147) AAMAA
IF3mt:4 C-domain KKK (184–186) AAA
IF3mt:5 C-domain HD (170–171) AA
IF3mt:6 C-domain K (175) A
IF3mt:7 C-domain K (194) A
IF3mt:8 C-domain EE (207–208) AA
IF3mt:9 C-extension EE (247–248) AA
IF3mt:10 C-extension KE (252–253) AA
IF3mt:11 C-extension DT (261–262) AA
IF3mt:12 C-extension KD (265–266) AA
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Table 2



















Mutated nucleotides are highlighted in gray. The reverse primers used were the inverse complements of the forward primers in each case. To
make the four amino acid mutations in IF3mt:1, four sequential mutations were required using primers 1a–1d sequentially. To make the four amino
acid mutations in IF3mt:3, two sequential mutagenic reactions were carried out using primers 3a and 3b as indicated.
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Table 3
Binding of IF3mt and its mutated derivatives to 28S mitochondrial ribosomesa
IF3mt Kd (nM)
IF3mt:WT 35 ± 13
IF3mt:5 19 ± 11
IF3mt:6 45 ± 17
a
Kd values of IF3mt:WT and its mutated derivatives binding to 28S mitochondrial ribosomes as determined by Microcon centrifugation.
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